Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT03551717
Other study ID # MEILLON AOI 2017
Secondary ID
Status Terminated
Phase
First received
Last updated
Start date March 14, 2018
Est. completion date April 19, 2019

Study information

Verified date May 2020
Source Centre Hospitalier Universitaire Dijon
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The main objective of this study is to investigate whether there are links between the blood vessels of the retina as a whole and heart and/or vascular diseases (cardiovascular diseases).

The arteries and veins of the retina are, like the large vessels of the human body (aorta, coronary, cerebral arteries), exposed to the complications of hypertension, diabetes, obesity, dyslipidemia (abnormal blood lipid profile) or tobacco. Several studies have shown that changes in retinal vessels (microvascularization) generally occur several years before damage to large peripheral vessels (macrovascularization). The study of the vessels of the retina is now possible thanks to simple and non-invasive examinations of photographs (not creating any lesion). They allow a painless evaluation of the vessels in the retina.

Ultimately, if this study is conclusive, the patient's cardiovascular risk could be evaluated simply by analysis of the vessels of the retina.

The study is being conducted in the ophthalmology and cardiology departments of Dijon University Hospital. In total, the investigators wish to include approximately 510 patients who present cardiovascular risk factors (255 low risk patients recruited in the ophthalmology department and 255 high risk patients hospitalized in the cardiology department).

All patients participating in the study will be asked to visit the ophthalmology department for a complete examination of the retina.


Recruitment information / eligibility

Status Terminated
Enrollment 155
Est. completion date April 19, 2019
Est. primary completion date April 19, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Person who gave oral consent

- High cardiovascular risk group: Adult patients hospitalized in the Cardiology Department of the University Hospital of Dijon Burgundy for acute coronary syndrome, patients between D1 and D5 of acute coronary syndrome, who can be moved for an ophthalmology consultation where the retinal imaging is done (heart monitoring in the presence of an experienced cardiologist if necessary)

- Low cardiovascular risk group: Adult patients over 40 years of age recruited in the Ophthalmology Department of the University Hospital of Dijon Burgundy following a standard consultation for cataract surgery, ocular surface pathologies and optical correction.

Exclusion Criteria:

- Person not affiliated to national health insurance

- Patient refusal

- Minor patient

- Protected patient

- Ophthalmological history (macular vascular or degenerative disorders)

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Optical Coherence Tomography angiography
At the inclusion visit for all patients and at M3 only for 50 patients.
Fundus
At the inclusion visit for all patients and at M3 only for 50 patients.
cardiac ultrasound scan
Only for 50 patients, 3 months after the initial cardiovascular event

Locations

Country Name City State
France Chu Dijon Bourogne Dijon

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire Dijon

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Surface of the avascular zone in the central retina Baseline